Skip to content

Advertisement

  • Poster presentation
  • Open Access

Coupled plasma filtration and adsorption in septic shock: a multicentric experience

  • 1,
  • 1,
  • 2,
  • 2,
  • 2,
  • 3 and
  • 3
Critical Care201014 (Suppl 1) :P412

https://doi.org/10.1186/cc8644

  • Published:

Keywords

  • Norepinephrine
  • Septic Shock
  • Multicentric Study
  • Inflammatory Marker
  • Organ Dysfunction

Introduction

Recently extracorporeal removal of mediators and endotoxins improved haemodynamics, organ dysfunction and mortality in patients with abdominal sepsis [1]. Coupled plasma filtration and adsorption (CPFA), too, may improve haemodynamics, respiratory function and mortality through removal of proinflammatory mediator. The aim of this multicentric study is to evaluate the haemodynamic response and the respiratory function, and to evaluate the reduction of inflammatory markers during CPFA.

Methods

Fifty-five septic patients were enrolled in this study. Every patient had four CPFA treatments (LINDA; Bellco-Mirandola, Italy) for 8 hours with Qb = 200 ml/minute, Qultrafiltration = 30 ml/kg/hour and Qplasma = 20% of Qb. At T0 (basal), T1 (after first cycle), T2 (after second cycle), T3 (after third cycle) and T4 (after fourth cycle) we evaluated haemodynamic parameters, norepinephrine dosage, PaO2/FiO2 ratio, plasma IL-6, and procalcitonin (PCT). The ANOVA test was used to compare changes during times study. P < 0.05 was considered statistically significant.

Results

Patients enrolled in the study have been submitted to 256 CPFA treatments for 2,650 hours. Table 1 presents the main results of the study. IV quartile of IL-6 is shown in Table 1.

Table 1

 

T0

T4

IL-6 (pg/ml)

850 ± 127

125 ± 28*

PCT (pg/ml)

45 ± 9

6 ± 2**

Noradrenaline (μg/kg/min)

0.35 ± 0.09

0.08 ± 0.05**

PaO2/FIO2

198 ± 28

310 ± 92**

*P < 0.05, **P < 0.01 vs T0.

Conclusions

In this large multicentric study, CPFA may improve haemodynamic status and respiratory function. Plasma filtration and adsorption of proinflammatory mediators may explain this improvement. Larger randomized controlled trials are indicated to confirm these data.

Authors’ Affiliations

(1)
European Aurelia Hospital, Rome, Italy
(2)
University of Tor Vergata, Rome, Italy
(3)
University of Trieste, Italy

References

  1. Cruz D, et al.: JAMA. 2009, 23: 2445-2452. 10.1001/jama.2009.856View ArticleGoogle Scholar

Copyright

© BioMed Central Ltd. 2010

Advertisement